Forest Labs to acquire Clinical Data
Forest Laboratories Inc. plans to buy specialty pharmaceutical firm Clinical Data Inc. in a deal valued at $1.2 billion. The companies said Tuesday that under the agreement, Forest will acquire Clinical Data for $30 per share in cash plus up to $6 per share upon achievement of certain commercial